Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury
- PMID: 16505177
- DOI: 10.1161/CIRCULATIONAHA.105.575993
Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury
Abstract
Background: The beneficial effects of reperfusion therapies have been limited by the amount of ischemic damage that occurs before reperfusion. To enable development of interventions to reduce cell injury, our research has focused on understanding mechanisms involved in cardiac cell death after ischemia/reperfusion (I/R) injury. In this context, our laboratory has been investigating the role of the receptor for advanced-glycation end products (RAGE) in myocardial I/R injury.
Methods and results: In this study we tested the hypothesis that RAGE is a key modulator of I/R injury in the myocardium. In ischemic rat hearts, expression of RAGE and its ligands was significantly enhanced. Pretreatment of rats with sRAGE, a decoy soluble part of RAGE receptor, reduced ischemic injury and improved functional recovery of myocardium. To specifically dissect the impact of RAGE, hearts from homozygous RAGE-null mice were isolated, perfused, and subjected to I/R. RAGE-null mice were strikingly protected from the adverse impact of I/R injury in the heart, as indicated by decreased release of LDH, improved functional recovery, and increased adenosine triphosphate (ATP). In rats and mice, activation of the RAGE axis was associated with increases in inducible nitric oxide synthase expression and levels of nitric oxide, cyclic guanosine monophosphate (cGMP), and nitrotyrosine.
Conclusions: These findings demonstrate novel and key roles for RAGE in I/R injury in the heart. The findings also demonstrate that the interaction of RAGE with advanced-glycation end products affects myocardial energy metabolism and function during I/R.
Similar articles
-
Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells.Antioxid Redox Signal. 2011 Oct 1;15(7):1769-78. doi: 10.1089/ars.2010.3764. Epub 2011 Apr 26. Antioxid Redox Signal. 2011. PMID: 21126209
-
The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury.Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E841-52. doi: 10.1152/ajpendo.00075.2012. Epub 2012 Jul 24. Am J Physiol Endocrinol Metab. 2012. PMID: 22829582
-
Nitric oxide signaling in ischemic heart.Cardiovasc Res. 1995 Oct;30(4):593-601. Cardiovasc Res. 1995. PMID: 8575007
-
Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury.Ann N Y Acad Sci. 2005 Jun;1043:702-9. doi: 10.1196/annals.1333.081. Ann N Y Acad Sci. 2005. PMID: 16037296 Review.
-
Advanced glycation end product receptor-mediated cellular dysfunction.Ann N Y Acad Sci. 2005 Jun;1043:676-80. doi: 10.1196/annals.1333.077. Ann N Y Acad Sci. 2005. PMID: 16037292 Review.
Cited by
-
Perioperative Open-lung Approach, Regional Ventilation, and Lung Injury in Cardiac Surgery.Anesthesiology. 2020 Nov 1;133(5):1029-1045. doi: 10.1097/ALN.0000000000003539. Anesthesiology. 2020. PMID: 32902561 Free PMC article. Clinical Trial.
-
A soluble receptor for advanced glycation end-products inhibits hypoxia/reoxygenation-induced apoptosis in rat cardiomyocytes via the mitochondrial pathway.Int J Mol Sci. 2012;13(9):11923-11940. doi: 10.3390/ijms130911923. Epub 2012 Sep 20. Int J Mol Sci. 2012. PMID: 23109892 Free PMC article.
-
Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome.Biomed Res Int. 2015;2015:815942. doi: 10.1155/2015/815942. Epub 2015 Sep 30. Biomed Res Int. 2015. PMID: 26491690 Free PMC article. Review.
-
Glycation abolishes the cardioprotective effects of albumin during ex vivo ischemia-reperfusion.Physiol Rep. 2017 Jan;5(2):e13107. doi: 10.14814/phy2.13107. Epub 2017 Jan 26. Physiol Rep. 2017. PMID: 28126733 Free PMC article.
-
Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: With Stops Along the Way in the Lung, Heart, Blood Vessels, and Adipose Tissue.Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):614-627. doi: 10.1161/ATVBAHA.120.315527. Epub 2020 Dec 17. Arterioscler Thromb Vasc Biol. 2021. PMID: 33327744 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources